Reaction
Miliaria reporting signals
As of the last recalculation, Miliaria appears in 1,673 FAERS reports alongside 28 co-occurring drug terms. The strongest observed disproportionality signal is DICLOFENAC POTASSIUM, FILM COATED (PRR 17.9).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Diclofenac Potassium, Film Coated | 12 | 17.9 | 17.9 |
| Diclofenac Potassium Tablets | 12 | 17.8 | 17.9 |
| Diclofenac Potassium | 13 | 15.1 | 15.1 |
| Diltiazem Hydrochloride Extended-Release Tablets | 12 | 13.2 | 13.2 |
| Dimethyl Fumarate | 94 | 10.0 | 10.0 |
| Niraparib | 17 | 9.6 | 9.6 |
| Apalutamide | 8 | 8.5 | 8.5 |
| Avapritinib | 8 | 8.3 | 8.3 |
| Ritonavir 100 Mg | 8 | 6.7 | 6.7 |
| Dupilumab | 224 | 6.5 | 6.5 |
| Vilazodone Hydrochloride | 4 | 5.4 | 5.4 |
| Asfotase Alfa | 4 | 5.0 | 5.0 |
| Vibegron | 3 | 4.7 | 4.7 |
| Brexpiprazole | 6 | 4.5 | 4.5 |
| Rucaparib | 3 | 4.2 | 4.2 |
| Diroximel Fumarate | 4 | 4.2 | 4.2 |
| Bosutinib | 3 | 4.2 | 4.2 |
| Ribavirin | 21 | 4.1 | 4.1 |
| Nemolizumab-Ilto | 4 | 3.9 | 3.9 |
| Crisaborole | 3 | 3.9 | 3.9 |
| Pirfenidone | 10 | 3.1 | 3.1 |
| Alirocumab | 6 | 3.0 | 3.0 |
| Ixekizumab | 8 | 2.7 | 2.7 |
| Relugolix | 5 | 2.6 | 2.6 |
| Adapalene | 36 | 2.5 | 2.5 |
| Palivizumab | 3 | 2.4 | 2.4 |
| Abaloparatide | 5 | 2.1 | 2.1 |
| Salicylic Acid | 7 | 1.6 | 1.6 |